We’ve all heard that 3D printing is getting increasingly sophisticated, from printing components for buildings and cars and whatnot. And 3D printing in healthcare is no different.
The latest example comes from a company that created a 3D-printed heart model to support a 16-year-old patient with a tumor at Cincinnati Children’s Hospital.
Belgium-based Materialise, which specializes in 3D printing for medical applications, was approached by Dr. Michael Taylor, the director of advanced imaging at The Heart Institute regarding the patient’s condition.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Bradley White, the patient, was born with a heart tumor and has had numerous open-heart surgeries since he was three-years old, and has a defibrillator implanted to protect against sudden cardiac death. But he recently was back in the hospital for yet another procedure to stop the electrical interference caused by the large cardiac tumor.
Dr. Tayler asked Materialise to create a 3-D replica of Bradley’s heart using Mimics Innovation Suite software, modeled on CT scan data. The 3-D printed replica allowed physicians to better understand the complex relationship of the tumor, printed in a hard, opaque material, and surrounding anatomical structures printed in a flexible, transparent material. That let the team of doctors proceed with an electrophysiology study and catheter ablation over a risky surgical resection of the tumor.
The replica also revealed just how big the tumor on Brand’s heart is, which surprised Bradley himself.
“I always thought my tumor was the size of a quarter and didn’t realize how large it was until I saw the [Materialise] model,” he said in an announcement from the company. “It’s one of the coolest things I’ve seen by far.”
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Materialise is hoping to expand its 3D printing capabilities further into healthcare, and clinicians at Cincinnati Children’s think it can be a great use of technology applied to healthcare and imaging.
“I think 3D Printing will clinically take us to the next generation of imaging. This is our future,” said Dr. David Morale, a cardiothoracic surgeon at Cincinnati Children’s.
Check out the video version here:
